Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05862454

Magnesium Injection Ensures Steroid Avoidance During Vaccine, Viremia or Immunocompromise

Magnesium Injection Ensures Analgesia and Steroid Avoidance During Vaccination, Viremia or Immunocompromise

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Salem Anaesthesia Pain Clinic · Academic / Other
Sex
All
Age
20 Years – 99 Years
Healthy volunteers
Accepted

Summary

Steroid injections are used for interventional pain management. However, their side-effect of immunosuppression may increase the risk of infections. Magnesium is an alternative anti-nociceptive injection that may be used instead of steroids. Prospective observational study of patients who received magnesium injection for interventional pain therapy, instead of steroid injection. Post-injection data collection includes numerical rating pain score, and sleep quality score. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant.

Detailed description

Corticosteroid injections are used for interventional pain management. The immunosuppression effect of steroid injection may increase the risk of infections. Magnesium is an alternative anti-nociceptive agent that may be used for interventional pain injection therapy, instead of steroids. Prospective observational clinical study of pain clinic patients who received magnesium injection for interventional pain therapy, instead of steroid injection. Post-injection data collection includes numerical rating pain score, and sleep quality score. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant. Data analyzed with IBM® SPSS® Statistics 25 (IBM Corp, Armonk, NY); using Student's t-test, ANOVA, Pearson Chi-square test, and regression analysis. P-value \<0.05 is considered significant.

Conditions

Interventions

TypeNameDescription
DRUGMagnesiumMagnesium injection therapy

Timeline

Start date
2020-07-02
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2023-05-17
Last updated
2025-01-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05862454. Inclusion in this directory is not an endorsement.